PH24513A - 3-aryl-5-alkylthio-4h-1,2,4-triazoles - Google Patents

3-aryl-5-alkylthio-4h-1,2,4-triazoles

Info

Publication number
PH24513A
PH24513A PH36413A PH36413A PH24513A PH 24513 A PH24513 A PH 24513A PH 36413 A PH36413 A PH 36413A PH 36413 A PH36413 A PH 36413A PH 24513 A PH24513 A PH 24513A
Authority
PH
Philippines
Prior art keywords
triazoles
alkylthio
aryl
Prior art date
Application number
PH36413A
Other languages
English (en)
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of PH24513A publication Critical patent/PH24513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH36413A 1987-01-27 1988-01-27 3-aryl-5-alkylthio-4h-1,2,4-triazoles PH24513A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US706387A 1987-01-27 1987-01-27
US07/126,191 US4900743A (en) 1987-01-27 1987-12-04 3-aryl-5-alkylthio-4H-1,2,4-triazoles

Publications (1)

Publication Number Publication Date
PH24513A true PH24513A (en) 1990-07-18

Family

ID=26676435

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36413A PH24513A (en) 1987-01-27 1988-01-27 3-aryl-5-alkylthio-4h-1,2,4-triazoles

Country Status (19)

Country Link
US (1) US4900743A (sv)
EP (1) EP0276793B1 (sv)
JP (1) JP2537651B2 (sv)
KR (1) KR960007166B1 (sv)
CN (1) CN1023480C (sv)
AR (1) AR244682A1 (sv)
AU (1) AU601013B2 (sv)
CA (1) CA1312605C (sv)
DE (1) DE3881712T2 (sv)
DK (1) DK171599B1 (sv)
ES (1) ES2058144T3 (sv)
FI (1) FI91526C (sv)
HU (1) HU205747B (sv)
IE (1) IE61188B1 (sv)
IL (1) IL85185A (sv)
NO (1) NO166642C (sv)
NZ (1) NZ223260A (sv)
PH (1) PH24513A (sv)
PT (1) PT86623B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2948189A (en) * 1987-12-31 1989-08-01 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
AU644500B2 (en) * 1990-12-20 1993-12-09 Merrell Dow Pharmaceuticals Inc. 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
DE4339412A1 (de) * 1993-11-18 1995-05-24 Bayer Ag Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen
AR032653A1 (es) 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
CN1736381B (zh) * 2005-08-11 2010-09-08 沈阳药科大学 吗啉甲基萘满酮用于制备平滑肌解痉剂的用途
AU2009325178A1 (en) * 2008-12-12 2010-06-17 Astrazeneca Ab A new process for preparing 4- [4-methyl-5- (Cl- 10alkylthio/C5-10aryl-Cl-6alkylthio) -4H-1, 2, 4-triazol-3- YL] pyridines.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193891B (en) * 1984-02-07 1987-12-28 Gyogyszerkutato Intezet Process for production of new derivatives of 1,2,4-triasole

Also Published As

Publication number Publication date
FI91526C (sv) 1994-07-11
FI91526B (sv) 1994-03-31
NO880337L (no) 1988-07-28
DE3881712T2 (de) 1993-12-23
NZ223260A (en) 1991-07-26
IE61188B1 (en) 1994-10-19
IL85185A0 (en) 1988-07-31
JPS63201176A (ja) 1988-08-19
DK171599B1 (da) 1997-02-17
ES2058144T3 (es) 1994-11-01
PT86623B (pt) 1993-01-29
AU601013B2 (en) 1990-08-30
EP0276793A2 (en) 1988-08-03
NO166642C (no) 1991-08-21
AU1072888A (en) 1988-07-28
HU205747B (en) 1992-06-29
DK35488D0 (da) 1988-01-26
FI880282A0 (sv) 1988-01-22
DK35488A (da) 1988-07-28
KR880008999A (ko) 1988-09-13
PT86623A (pt) 1988-02-01
NO880337D0 (no) 1988-01-26
KR960007166B1 (ko) 1996-05-29
CN1023480C (zh) 1994-01-12
FI880282A (sv) 1988-07-28
CN88100346A (zh) 1988-11-02
US4900743A (en) 1990-02-13
EP0276793A3 (en) 1988-09-21
DE3881712D1 (de) 1993-07-22
IL85185A (en) 1996-03-31
HUT47257A (en) 1989-02-28
NO166642B (no) 1991-05-13
CA1312605C (en) 1993-01-12
AR244682A1 (es) 1993-11-30
EP0276793B1 (en) 1993-06-16
JP2537651B2 (ja) 1996-09-25

Similar Documents

Publication Publication Date Title
JPS6419070A (en) 1,5-substituted 1h-imidazole
ZA884603B (en) 2,5-dihydropyrroles
EG18122A (en) 1-dimethylcarbamoyl-3-t-butyl-5-substituted-1h-1,2,4-triazoles
ZA889710B (en) 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
PH25616A (en) 1,2,3,4-tetrahydro-5-nitro-pyrimidine derivatives
ZA865446B (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4-triazoles
AR244682A1 (es) Procedimiento para preparar derivados de 3-aril-5-alquiltio-4h-1,2,4-triazoles.
EP0316843A3 (en) 1,2,3,4-tetrahydro-5-nitropyrimidine derivatives
IL83679A0 (en) 2,4,6-trihydroxy-s-triazine derivatives
GR3000539T3 (en) 3,4-dihydro-2h-pyrans
JPS6450861A (en) 3,5-dialkyl-1-arylpyrazoles
CS569987A1 (en) Zpusob vyroby 2 naftylamin 6,8 disulfonove kyseliny
ZA88525B (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles
CS22787A1 (en) Zpusob pripravy 2,6-dialkoxybenzonitrilu
IE860654L (en) 1, 2, 4 - triazoles
IE883874L (en) 4-aralkyl-5-substituted-1,2,4-triazoles
IE890773L (en) 1, 2, 4 - triazoles
IE891066L (en) 1,2,4-triazoles
IE871771L (en) 1,4-piperazines
CS770787A1 (en) Sposob pripravy 2,2 dibenzotiazolyldisulfidu
IE872988L (en) 2,6-diamino-3-halobenzylpyridines
CS569887A1 (en) Zpusob izolace 2 naftol 6,8 disulfonove kyseliny
CS689087A1 (en) Zpusob vyroby 2,5 dichloranilin 4 sulfonove kyseliny
IE871970L (en) 2,7-methanobenzoxazonines
CS553587A1 (en) 1 2 alkyltio 6 benzotiazolylaminometyl 5 3,4 di chlorfenyl 1,2,3,4 tetrazoly